Stephen Liu, Chief, Division of Hematology and Oncology at Georgetown Lombardi Comprehensive Cancer Center, shared on X:
“The lung cancer community at ESMO26 Presidential Symposium III here for Dr. Jarushka Naidoo discussant on phase III trial of reduced frequency IO.
One of the most brilliant minds in our field – always insightful, thoughtful, balanced.”
You can also read:
